Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-31 @ 5:06 PM
Study NCT ID:
NCT07073833
Status:
RECRUITING
Last Update Posted:
2025-07-18
First Post:
2025-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma
Sponsor:
Imbioray (Hangzhou) Biomedicine Co., Ltd.